External Source

Fda Biosimilars Action Plan

2018 1:38
Synopsis
Christine Simmon, Executive Director of AAM's Biosimilars Council, reacts to the recent release of FDA's Biosimilars Action Plan.

You Might Also Like

Biosimilars Interchangeability 2:03
Biosimilars Interchangeability
2021
Biosimilars: Approval Process 2:47
Biosimilars: Approval Process
2021
The Promise of Biosimilars 3:07
The Promise Of Biosimilars
2018
Data Requirements for Biosimilars 5:20
Data Requirements For Biosimilars
2018
Imron Aly, JD: The Biosimilar Action Plan 1:19
Imron Aly, Jd: The Biosimilar Action Plan
2018
Regulatory Highlights for Biosimilars and Interchangeables (9of15) REdI – May 29-30, 2019 42:43
Regulatory Highlights For Biosimilars And Interchangeables (...
2020
Interchangeable Biosimilars 1:36
Interchangeable Biosimilars
2023
Cultivating a vibrant U.S. market for biosimilars: A conversation with FDA’s Scott Gottlieb - Part 1 49:42
Cultivating A Vibrant U.s. Market For Biosimilars: A Convers...
2018
Biosimilars: Totality of the Evidence in Biosimilar Development 6:32
Biosimilars: Totality Of The Evidence In Biosimilar Developm...
2024
A look at the expansion of a biosimilar’s FDA label with Sue Naeyaert 1:36
A Look At The Expansion Of A Biosimilar’s Fda Label With S...
2016
Dr. Hurvitz on the FDA Approval Process for Biosimilars 1:55
Dr. Hurvitz On The Fda Approval Process For Biosimilars
2018
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.